HIV and Tuberculosis Trends in the United States and Select Sub-Saharan Africa Countries
Abstract
:1. Introduction
2. Methods
2.1. Data Collection
2.2. Statistical Analysis
3. Results and Discussion
3.1. Results
3.2. Discussion
4. Conclusions
Acknowledgments
References
- Russell, DG; Barry, CE, III; Flynn, JL. Tuberculosis: What we don’t know can, and does, hurt us. Science 2010, 328, 852–856. [Google Scholar]
- Lange, C; Mori, T. Advances in the diagnosis of tuberculosis. Respirology 2010, 15, 220–240. [Google Scholar]
- Jasmer, RM; Nahid, P; Hopewell, PC. Clinical practice. Latent tuberculosis infection. N. Engl. J. Med 2002, 347, 1860–1866. [Google Scholar]
- Kochi, A. Tuberculosis: Distribution, risk factors, mortality. Immunobiology 1994, 191, 325–336. [Google Scholar]
- Pluta, K; Kacprzak, MM. Use of HIV as a gene transfer vector. Acta Biochim. Pol 2009, 56, 531–595. [Google Scholar]
- Kilmarx, PH. Global epidemiology of HIV. Curr. Opin. HIV AIDS 2009, 4, 240–246. [Google Scholar]
- Klimas, N; Koneru, AO; Fletcher, MA. Overview of HIV. Psychosom. Med 2008, 70, 523–530. [Google Scholar]
- Carvalho, AC; Migliori, GB; Cirillo, DM. Tuberculosis in Europe: A problem of drug resistance or much more? Expert Rev. Respir. Med 2010, 4, 189–200. [Google Scholar]
- Dembele, M; Saleri, N; Carvalho, AC; Saouadogo, T; Hien, AD; Zabsonre, I; Koala, ST; Simpore, J; Matteelli, A. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int. J. Tuberc. Lung Dis 2010, 14, 318–323. [Google Scholar]
- Seung, KJ; Omatayo, DB; Keshavjee, S; Furin, JJ; Farmer, PE; Satti, H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One 2009, 4, e7186. [Google Scholar]
- Schneider, E; Castro, KG. Tuberculosis trends in the United States, 1992–2001. Tuberculosis (Edinb.) 2003, 83, 21–29. [Google Scholar]
- Fassin, D; Schneider, H. The politics of AIDS in South Africa: Beyond the controversies. BMJ 2003, 326, 495–497. [Google Scholar]
- Habib, AG. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults. Ann. Afr. Med 2009, 8, 147–155. [Google Scholar]
- Small, PM. Tuberculosis: A new vision for the 21st century. Kekkaku 2009, 84, 721–726. [Google Scholar]
- Assam-Assam, JP; Penlap, VB; Cho-Ngwa, F; Tedom, JC; Ane-Anyangwe, I; Titanji, VP. Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infect. Dis 2011, 11, 94. [Google Scholar]
- LoBue, PA; Enarson, DA; Thoen, TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int. J. Tuberc. Lung Dis 2010, 14, 1226–1232. [Google Scholar]
- Moore, RD. Epidemiology of HIV infection in the United States: Implications for linkage to care. Clin. Infect. Dis 2011, 52, S208–S213. [Google Scholar]
- UNAIDS. Report on the Global AIDS Epidemic. 2006. Available online: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2006/default.asp (accessed on 1 July 2010).
- WHO. 2007 Tuberculosis facts WHO. 2007. Available online: http://www.who.int/tb/publications/2007/factsheet_2007.pdf (accessed on 1 July 2010).
- UNAIDS. Frequently Asked Questions about Tuberculosis and HIV. 2006. Available online: http://data.unaids.org/pub/factsheet/2006/tb_hiv_qa.pdf (accessed on 1 July 2010).
- AVERT, HIV & AIDS in South Africa, 2010. Available online: www.avert.org/aidssouthafrica.htm (accessed on 1 July 2010).
- Fassin, D. The embodiment of inequality. AIDS as a social condition and the historical experience in South Africa. EMBO Rep 2003, 4, S4–S9. [Google Scholar]
- Mbanya, D; Ateudjieu, J; Tagny, CT; Moudourou, S; Lobe, MM; Kaptue, L. Risk factors for transmission of HIV in a hospital environment of Yaounde, Cameroon. Int. J. Environ. Res. Public Health 2010, 7, 2085–2100. [Google Scholar]
- Reid, SR. Injection drug use, unsafe medical injections, and HIV in Africa: A systematic review. Harm Reduct. J 2009, 6, 24. [Google Scholar]
- Aliyu, MH; Varkey, P; Salihu, HM; Iliyasu, Z; Abubakar, IS. The HIV/AIDS epidemic in Nigeria: Progress, problems and prospects. Afr. J. Med. Med. Sci 2010, 39, 233–239. [Google Scholar]
- Powell, R; Barengolts, D; Mayr, L; Nyambi, P. The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials. Viruses 2010, 2, 639–654. [Google Scholar]
- Kehinde, AO; Obaseki, FA; Ishola, OC; Ibrahim, KD. Multidrug resistance to Mycobacterium tuberculosis in a tertiary hospital. J. Natl. Med. Assoc 2007, 99, 1185–1189. [Google Scholar]
- Dau, B; Holodniy, M. The relationship between HIV infection and cardiovascular disease. Curr. Cardiol. Rev 2008, 4, 203–218. [Google Scholar]
- Boyer, S; Eboko, F; Camara, M; Abe, C; Nguini, ME; Koulla-Shiro, S; Moatti, JP. Scaling up access to antiretroviral treatment for HIV infection: The impact of decentralization of healthcare delivery in Cameroon. AIDS 2010, 24, S5–S15. [Google Scholar]
- Mbanya, D; Sama, M; Tchounwou, P. Current status of HIV/AIDS in Cameroon: How effective are control strategies? Int. J. Environ. Res. Public Health 2008, 5, 378–383. [Google Scholar]
- Arcand, JL; Wouabe, ED. Teacher training and HIV/AIDS prevention in West Africa: Regression discontinuity design evidence from the Cameroon. Health Econ 2010, 19, 36–54. [Google Scholar]
- Tchendjou, P; Same-Ekobo, C; Nga, A; Tejiokem, M; Kfutwah, A; Nlend, AN; Tsague, L; Bissek, AC; Ekoa, D; Orne-Gliemann, J; Rousset, D; Pouillot, R; Dabis, F. Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon. PLoS One 2010, 5, e10411. [Google Scholar]
Variable/Country | United States* | South Africa | Cameroon | Nigeria |
---|---|---|---|---|
HIV Cases | (0.3502 ± 0.0168)c | (7.9973 ± 3.6820)a | (2.9122 ± 0.6111)b | (1.5017 ± 0.3660)bc |
HIV Deaths | (0.0097 ± 0.0056)c | (0.3258 ± 0.2509)a | (0.1559 ± 0.0800)b | (0.0833 ± 0.0387)bc |
TB Cases | (0.0065 ± 0.0017)b | (0.3713 ± 0.1472)a | (0.0645 ± 0.0372)b | (0.0254 ± 0.0141)b |
TB Deaths | (0.0004± 0.0001)d | (0.1722 ± 0.0538)a | (0.0499 ± 0.0080)c | (0.0806 ± 0.0217)b |
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Mahmud, O.; Dates, C.; Akil, L.; Ahmad, H.A. HIV and Tuberculosis Trends in the United States and Select Sub-Saharan Africa Countries. Int. J. Environ. Res. Public Health 2011, 8, 2524-2532. https://doi.org/10.3390/ijerph8062524
Mahmud O, Dates C, Akil L, Ahmad HA. HIV and Tuberculosis Trends in the United States and Select Sub-Saharan Africa Countries. International Journal of Environmental Research and Public Health. 2011; 8(6):2524-2532. https://doi.org/10.3390/ijerph8062524
Chicago/Turabian StyleMahmud, Ousman, Centdrika Dates, Luma Akil, and Hafiz A. Ahmad. 2011. "HIV and Tuberculosis Trends in the United States and Select Sub-Saharan Africa Countries" International Journal of Environmental Research and Public Health 8, no. 6: 2524-2532. https://doi.org/10.3390/ijerph8062524